Tesamorelin is a synthetic polypeptide comprised of 44 amino acids similar to growth hormone-releasing hormone. The N-terminus of the molecule has been changed compared to growth hormone-releasing hormone (GHRH), which is hypothesized to lead to enhanced stability and pharmacokinetics. Tesamorelin also goes by its commercial (brand) name, Egrifta, or TH9507.